(6-Chloro-2-methanesulfonyl-pyrimidin-4-yl)-cyclopropyl-amine, 500mg

4-Cyanobutanoic acid, 95.0%, 250mg

Methyl (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, 95%, 1g

2-Chloronaphthalene-1,4-dione, 97.00%, 500g

2-Hydrazinyl-5-methyl-1,3,4-thiadiazole, 95.0%, 250mg

(S)-2-((tert-Butoxycarbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 97%, 5g

4-(Benzyloxy)cyclohexan-1-ol, 95+%, 1g

2-(4-Cyanophenyl)acetophenone, 97.0%, 1g

5,6-Dihydrocyclopenta[c]pyrrol-4(2H)-one, 95.0%, 5g

1-(Quinolin-2-yl)ethanone, 95.0%, 1g

2-Amino-6-iodotoluene, 95.0%, 5g

9-BROMO-10-[3-(2-NAPHTHYL)PHENYL]ANTHRACENE, 98%, 1g

4-Nitrophenyl alpha-D-Galactopyranoside [Substrate for alpha-D-Galactosidase]>98.0%(HPLC)200mg